Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of NICE - Depositary Receipt () (NasdaqGS:NICE) ...

Cantor Fitzgerald upgraded shares of Palantir Technologies (NASDAQ:PLTR – Free Report) to a hold rating in a research report ...

Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of MongoDB (NasdaqGM:MDB) with a Overweight ...

Cantor Fitzgerald upgraded shares of NICE (NASDAQ:NICE – Free Report) to a hold rating in a research note issued to investors on Thursday, MarketBeat reports. The brokerage currently has $176.00 price ...

Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...

Cantor Fitzgerald analyst Thomas Blakey initiated coverage of Five9 (FIVN) with an Overweight rating and $46 price target Stay Ahead of the ...

Weakness in Cantor Fitzgerald High Income A's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative. Our research team assigns Negative ratings to ...

Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75-million penalty to settle Securities and Exchange Commission charges that it misled investors in blank-check companies it ...

Cantor Fitzgerald initiated coverage of Cloudflare (NET) with a Neutral rating and $111 price target Stay Ahead of the Market:Discover ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The main driver of the rating is the parent firm's five-year risk-adjusted success ratio of 90%. The measure ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, commercial-stage biotechnology company with two approved ...